Article Data

  • Views 1874
  • Dowloads 129

Original Research

Open Access

The role of oxidative stress in premalignant lesions

  • G. Batmaz1,*,
  • E. Kılıç2
  • P. Özcan1
  • E.A. Sarıoğlu1
  • N. Karaca1
  • B. Dane1

1Bezmialem Vakif University, Department of Obstetrics and Gynecology Istanbul, Turkey

2Bezmialem Vakif University, Deparment of Medical Biochemistry, Istanbul, Turkey

DOI: 10.12892/ejgo3377.2017 Vol.38,Issue 2,April 2017 pp.282-285

Published: 10 April 2017

*Corresponding Author(s): G. Batmaz E-mail: drgoncabatmaz@yahoo.com

PDF (102.24 kB) View Full-text

Abstract

Purpose of Investigation: The authors aimed to evaluate serum total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) in women with abnormal cervical cytology, to determine the association between serum oxidant and antioxidant status of these women, and the progression of abnormal cervical cytology. Materials and Methods: A total of 75 women enrolled in the study: 20 women with a determination of atypical squamous cells of undetermined significance (ASCUS), 20 women with low squamous intraepithelial lesions (LSIL), 15 women with high squamous intraepithelial lesions (HSIL) and 20 healthy controls. Serum TOS and TAS were determined and OSI was calculated as the indicator of degree of oxidative stress. Results: Serum TOS levels and OSI were highest in the HSIL group and there was a trend toward increasing serum TOS levels and OSI from ASCUS to HSIL group. Conclusion: The authors demonstrated that increased oxidative stress with altered antioxidant level is associated with abnormal cervical cytology. Serum oxidant and antioxidant status may provide guidance as a simple and cost-effective method for follow-up, treatment, and recommendation in all stages of lesions.

Keywords

Total oxidant stress; Premalignant lesions; Abnormal cervical cytology.

Cite and Share

G. Batmaz, E. Kılıç, P. Özcan, E.a. Sarıoğlu, N. Karaca, B. Dane. The role of oxidative stress in premalignant lesions. European Journal of Gynaecological Oncology. 2017; 38(2): 282-285. doi: 10.12892/ejgo3377.2017

References

[1] Wilson DM., Sofinowski TM., McNeill DR.: “Repair mechanisms for oxidative DNA damage’’. Front Biosci., 2003, 8, 963.

[2] Saeidnia S., Abdollahi M.: “Toxicological and pharmacological concerns on oxidative stress and related diseases’’. Toxicol. Appl. Pharmacol., 2013, 273, 442.

[3] Klaunig JE., Kamendulis LM.: “The role of oxidative stress in carcinogenesis’’. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 239.

[4] Klaunig JE., Wang Z., Pu X., Zhou S.: “Oxidative stress and oxidative damage in chemical carcinogenesis’’. Toxicol. Appl. Pharmacol., 2011, 254, 86.

[5] Valko M., Rhodes CJ., Moncol J., Izakovic M., Mazur M.: “Free radicals, metals and antioxidants in oxidative stress-induced cancer’’. Chem. Biol. Interact., 2006, 160, 1.

[6] Marnett LJ.: “Oxyradicals and DNA damage’’. Carcinogenesis, 2000, 21, 361.

[7] Toyokuni S.: “Novel aspects of oxidative stress-associated carcinogenesis’’. Antioxid. Redox. Signal., 2006, 8, 1373.

[8] Moktar A., Singh R., Vadhanam MV., Ravoori S., Lillard JW., Gairola CG., Gupta RC.: “Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells’’. Int. J. Oncol., 2011, 39, 941.

[9] Beevi SS., Rasheed MH., Geetha A.: “Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma’’. Clin. Chim. Acta., 2007, 375, 119.

[10] Sgambato A., Zannoni GF., Faraglia B., Camerini A., Tarquini E., Spada D., Cittadini A.: “Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis’’. Gynecol. Oncol., 2004, 92, 776.

[11] Erel O.: “A new automated colorimetric method for measuring total oxidant status’’. Clin. Biochem., 2005, 38, 1103.

[12] Erel O.: “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation’’. Clin. Biochem., 2004, 37, 277.

[13] Harma M., Harma M., Erel O.: “Oxidative stress in women with preeclampsia’’. Am. J. Obstet. Gynecol., 2005, 192, 656.

[14] Feng JF., Lu L., Zeng P., Yang YH., Luo J., Yang YW., Wang D.: “Serum total oxidant/antioxidant status and trace element levels in breast cancer patients’’. Int. J. Clin. Oncol., 2012, 17, 575.

[15] Horoz M., Bolukbas C., Bolukbas FF., Sabuncu T., Aslan M., Sarifakiogullari S., Gunaydin N., et. al.: “Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis’’. BMC Gastroenterol., 2005, 5, 35.

[16] Carrero Y., Callejas D., Alaña F., Silva C., Mindiola R., Mosquera J.: “Increased vascular endothelial growth factor expression, CD3- positive cell infiltration, and oxidative stress inpremalignant lesions of the cervix’’. Cancer, 2009, 115, 3680.

[17] Looi ML., Mohd Dali AZ., Md Ali SA., Wan Ngah WZ., Mohd Yusof YA.: “Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix’’. Eur. J. Cancer Prev., 2008, 17, 555.

[18] Goncalves TL., Erthal F., Corte CL., Muller LG., Piovezan CM., Nogueira CW., Rocha JB.: “Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women’’. Clin. Biochem., 2005, 38, 1071.

[19] Mandic A., Vujkov T.: “Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? ’. Ann. Oncol., 2004, 15, 197.

[20] Schiffman M.H., Brinton L.A.: “The epidemiology of cervical carcinogenesis’’. Cancer, 1995, 10, 1888.

[21] Walboomers JMM., Jacobs MV., Manos MM., Bosch FX., Kummer JA., Shah KV., et al.: “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide’’. J. Pathol., 1999, 189, 12.

[22] Dalstein W., Riethmuller D., Pretet JL., Le Bail Carval K., Sautiere JL., Carbillet JP., et al.: “Persistence and load of high-risk HPVare predictors for development of high-grade cervical lesions: a longitudinal French cohort study’’. Int J Cancer., 2003,106,396.

[23] Burd E.M.: “ Human papillomavirus and cervical cancer”. Clin. Microbiol. Rev., 2003, 16, 1.

[24] Halliwell B., Gutteridge JMC.: “Lipid peroxidation oxygen radicals, cell domage and antioxidant therapy’’. Lancet, 1984, 23, 1396.

[25] Luo C., Urgard E., Vooder T., Metspalu A.: “The role of COX-2 and Nrf2/ARE in antiinflammation and antioxidative stress: aging and anti-aging’’. Med. Hypotheses, 2011, 77, 174.

[26] Block G., Patterson B., Subar A.: “Fruit vegetables, and cancer prevention: a review of epidemiological evidence’’. Nutr. Cancer, 1992, 18, 1.

[27] Sporn MB.: “Carcinogenesis and cancer: different perspectives on the same disease’’. Cancer Res., 1991, 5, 6215.

[28] D'Archivio M., Santangelo C., Scazzocchio B., Vari R., Filesi C., Masella R., Giovannini C.: “Modulatory effects of polyphenols on apoptosis induction: relevance for cancer prevention’’. Int. J. Mol. Sci., 2008, 9, 213.

[29] Siegel EM., Salemi JL., Villa LL., Ferenczy A., Franco EL., Giuliano AR.: “Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia’’. Gynecol. Oncol., 2010, 118, 289.

[30] Tomita LY., Longatto Filho A., Costa MC., Andreoli MA., Villa LL., Franco EL., Cardoso MA.: “Brazilian Investigation into Nutrition and Cervical Cancer Prevention (BRINCA) Study Team, Diet and serummicronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women’’. Int. J. Cancer, 2010, 126, 703.

[31] Schlesier K., Harwat M., Bohm V., Bitsch R.: “Assessment of antioxidant activity by using different invitro methods’’. Free Radic. Res., 2002, 36, 177.

[32] Janaszewska A., Bartosz G.: “Assay of total antioxidant capacity: comparison off our methods as applied to human blood plasma’’. Scand. J. Clin. Lab. Invest., 2002, 62, 231.

Submission Turnaround Time

Top